Earlier Detection

We prioritize based on the potential to lead to progress on our strategic goals of Earlier Detection, Quality of Life, Better Prevention and Improved Treatment.

Prostate Cancer Research Reaches Significant Milestone

This clinical trial milestone has also allowed Dr. Lewis and his team to collect and store more than 100,000 patient samples in the Alberta Prostate Cancer Biorepository, the largest prostate collection in the world.

One in six Alberta men will be diagnosed with prostate cancer in their lifetime, and more than 2,700 will be diagnosed with prostate cancer in Alberta this year alone.

Thanks to you, vital advancements that will improve the lives of many patients are being made in the lab of the Alberta Cancer Foundation’s Frank and Carla Sojonky Chair in Prostate Cancer Research held by Dr. John Lewis.

Our research projects are working with a line of sight to the patients who are living with prostate cancer. Our overarching goal is to make an impact on patients with prostate cancer, ideally in the short term. Our team-made up of scientists and physicians throughout Alberta, around Canada and internationally--is working hard to make that happen.

- Dr. John Lewis

Together we can continue to provide Albertans with the best possible treatment and care available.